Skip to main content
. 2020 Mar 20;20:88. doi: 10.1186/s12935-020-1156-8

Fig. 4.

Fig. 4

ROC curves show the AUC of the four-DNA methylation biomarker (0.71, 95% CI 0.66–0.77) and other known biomarker such as miRNAs (0.52, 95% CI 0.45–0.58) and PODXL (0.55, 95% CI 0.49–0.61) in predicting the OS of GC patients, meth_RS: methylation ROC analysis, miRNA_RS: miRNA ROC analysis